Verdict: Over-annotated — removal recommended.
The peroxisome (GO:0005777) annotation for Drosophila melanogaster Acat1 (Q9W3N9) is over-annotated and should be removed. The annotation rests solely on an ISM (In Silico Method) computational prediction from Faust et al. 2012 (PMID: 22758915), and twelve converging lines of evidence refute peroxisomal localization while strongly supporting mitochondrial localization. Critically, Acat1 was not among the proteins whose peroxisomal localization was experimentally confirmed by Faust et al. — a decisive finding that removes any ambiguity about the annotation's evidential basis. The mitochondrion annotation (GO:0005739), supported by HDA evidence from LOPIT proteomics, should be retained as the primary cellular component annotation.
This investigation evaluated whether the GO cellular component annotation "peroxisome" (GO:0005777) is justified for Drosophila melanogaster Acat1 (acetoacetyl-CoA thiolase, UniProt Q9W3N9). The annotation was assigned via ISM (In Silico Method) evidence from PMID: 22758915 (Faust et al. 2012), a study that computationally predicted peroxisomal proteins in Drosophila and experimentally confirmed only a subset.
Through three iterations of systematic investigation — encompassing evidence audit, sequence analysis, structural modeling, cross-species ortholog comparison, and literature review — we assembled twelve independent lines of evidence that collectively refute peroxisomal localization for Acat1. The most decisive finding came from querying QuickGO for proteins that received IDA (Inferred from Direct Assay) evidence from PMID:22758915: Acat1 is absent from that list. The six experimentally confirmed peroxisomal proteins are Agps, CRAT, Ccs, CG17544, Mtpalpha, and Sod1 — not Acat1. This means Acat1 was computationally predicted but never validated, and the ISM annotation represents an unconfirmed computational hypothesis rather than an experimentally supported localization.
Supporting this conclusion, LOPIT proteomics (PMID: 19317464) experimentally maps Acat1 to mitochondria (HDA evidence). Sequence analysis reveals Acat1's C-terminal tripeptide (-EKL) is non-canonical for PTS1 targeting, is structurally embedded in the thiolase catalytic fold (AlphaFold pLDDT >97), and is conserved across 94% of insect ACAT1 orthologs as a catalytic motif — not a targeting signal. The N-terminus shows disordered MTS (mitochondrial targeting sequence) character consistent with human ACAT1. Furthermore, Drosophila is a cholesterol auxotroph, eliminating the cholesterol biosynthesis pathway that provides the mammalian rationale for dual peroxisomal/mitochondrial thiolase targeting.
Systematic audit of the evidence basis in QuickGO revealed a stark asymmetry. The peroxisome annotation (GO:0005777) for Acat1 is supported by a single line of evidence: ISM (In Silico Method) from PMID: 22758915, dated 2013-08-15. In contrast, the mitochondrion annotation (GO:0005739) has three independent lines of evidence: HDA (High-throughput Direct Assay) from PMID: 19317464 based on LOPIT proteomics of Drosophila embryos, IBA (Inferred from Biological Ancestor) from GO_Central, and ISM from PMID: 22758915. The LOPIT study, which simultaneously maps proteins to subcellular compartments using mass spectrometry, provides the most direct experimental evidence and assigns Acat1 to mitochondria. No experimental evidence of any kind supports peroxisomal localization.
{{figure:evidence_summary.png|caption=Evidence comparison for mitochondrial vs. peroxisomal localization of Acat1, showing the asymmetry between ISM-only peroxisomal evidence and multi-evidence mitochondrial support}}
Peroxisomal matrix protein import in Drosophila relies exclusively on the PTS1 pathway, as Faust et al. 2012 noted: "Similar to Caenorhabditis elegans, Drosophila appears to only utilize the peroxisome targeting signal type 1 system for matrix protein import" (PMID: 22758915). The canonical PTS1 consensus is -[SACGP][KRH][LM]. Acat1's C-terminal tripeptide is -EKL (Glu-Lys-Leu), where glutamic acid at position -3 is negatively charged and strongly disfavors PTS1 function. By comparison, Drosophila ScpX (Q24506) — the likely peroxisomal thiolase for fatty acid β-oxidation — terminates in the canonical -SKL. Human ACAT1 (P24752) ends in -QKL, also non-canonical, and is annotated exclusively as mitochondrial in UniProt.
No PTS2 motif (consensus: -R[LIV]x₅[HQ][LA]-) was identified in the Acat1 N-terminal sequence, and since Drosophila appears to lack the PTS2 import pathway entirely, this eliminates the alternative peroxisomal import mechanism observed in organisms like Dictyostelium (PMID: 25911059), where ACAT can use PTS2 for dual localization.
Acat1's GO annotations for molecular function and biological process include acetyl-CoA C-acetyltransferase activity, ketone body catabolic process, L-isoleucine catabolic process, and acetyl-CoA biosynthetic process (all ISS evidence). These are characteristic of thiolase II (biosynthetic/acetoacetyl-CoA thiolase), which functions in the mitochondrial matrix for ketone body metabolism and branched-chain amino acid catabolism. InterPro classifies Q9W3N9 as a member of the thiolase family (IPR002155) with thiolase N-terminal (PF00108) and C-terminal (PF02803) domains.
The peroxisomal thiolase involved in fatty acid β-oxidation is a distinct enzyme type (thiolase I / 3-ketoacyl-CoA thiolase), represented in Drosophila by ScpX. In mammals, the dual localization of ACAT1 to both mitochondria and peroxisomes is linked to cholesterol biosynthesis (PMID: 11108725). However, Drosophila melanogaster is a cholesterol auxotroph (PMID: 18682733): "we provide evidence for a preservation of the corresponding genes in two animals unable to synthesize cholesterol de novo (auxotrophs): Drosophila melanogaster and Caenorhabditis elegans." This eliminates the metabolic rationale for peroxisomal ACAT1 in flies.
Analysis of the AlphaFold structure (AF-Q9W3N9-F1, v6) provided structural evidence consistent with mitochondrial, not peroxisomal, targeting:
{{figure:iteration2_evidence.png|caption=AlphaFold pLDDT analysis of Acat1 showing disordered N-terminal MTS region (pLDDT 44–64) and high-confidence structured C-terminal -EKL (pLDDT >97), alongside insect ortholog conservation data}}
Analysis of 16 insect ACAT1 orthologs spanning five orders (Diptera, Hymenoptera, Lepidoptera, Hemiptera, and Coleoptera), representing over 350 million years of divergence, revealed striking conservation: 15 of 16 orthologs (94%) terminate in -EKL, with one ending in -ERL. The extended motif ...GASS[IM][LM]I[EQ]KL is highly conserved, forming part of the thiolase catalytic core. No insect ACAT1 ortholog has a canonical PTS1 motif (e.g., -SKL, -AKL, -SRL). This deep conservation as a catalytic motif, rather than a targeting signal, provides powerful evolutionary evidence that -EKL is enzymatically required and not a peroxisomal targeting peptide.
This was the decisive finding that closed the key knowledge gap. Querying QuickGO for all Drosophila proteins with IDA (ECO:0000314) evidence for GO:0005777 (peroxisome) from PMID: 22758915 identified six experimentally confirmed proteins: Agps, CRAT, Ccs, CG17544, Mtpalpha, and Sod1. Acat1 (Q9W3N9) is not among them. This is consistent with the paper's own statement: "The subcellular localization of five of these predicted peroxisomal proteins was confirmed" (PMID: 22758915).
Acat1 received only the ISM annotation — it was computationally predicted as potentially peroxisomal but its localization was never experimentally verified. This definitively establishes that the GO:0005777 annotation is an unvalidated computational prediction.
{{figure:final_evidence_summary.png|caption=Comprehensive evidence summary showing all twelve lines of evidence converging on the over-annotation verdict, including the decisive finding that Acat1 was not experimentally confirmed by Faust et al. 2012}}
| Citation | Evidence Type | Direction | Claim Tested | Key Finding | Context | Confidence & Limitations |
|---|---|---|---|---|---|---|
| PMID: 22758915 | Computational (ISM) | Source / qualifies | Acat1 is peroxisomal | Computational prediction only; Acat1 NOT among 5–6 experimentally confirmed proteins | Drosophila proteome analysis | Low for Acat1: prediction-only, unvalidated |
| PMID: 19317464 | Direct assay (HDA, LOPIT) | Supports mitochondrial | Acat1 subcellular localization | LOPIT mass spectrometry maps Acat1 to mitochondria | Drosophila embryos | High: direct experimental organelle mapping |
| PMID: 18682733 | Computational/review | Supports removal | Metabolic rationale for dual targeting | Drosophila is cholesterol auxotroph; no cholesterol biosynthesis pathway | Drosophila, C. elegans | High: eliminates mammalian dual-targeting rationale |
| PMID: 25911059 | Direct assay (GFP) | Competing | Dual localization precedent | Dictyostelium ACAT uses PTS2 for dual localization | Dictyostelium | Moderate: organism differs; Drosophila lacks PTS2 pathway |
| PMID: 11108725 | Direct assay | Competing | Mammalian ACAT1 has PTS1 | Mammalian thiolase has both MTS and PTS1 for cholesterol biosynthesis | Mammalian cells | Not applicable to Drosophila; cholesterol synthesis absent |
| PMID: 8858167 | Direct assay | Qualifies | PTS1 receptor mechanism | Pex13p/Pex5p require accessible C-terminal PTS1 | S. cerevisiae | High: conserved mechanism |
| AlphaFold AF-Q9W3N9-F1 | Structural/computational | Supports removal | C-terminal accessibility | -EKL has pLDDT >97 and is buried; N-terminus disordered (MTS-like) | Computational prediction | Moderate: predicted structure, not experimental |
| Ortholog analysis (16 spp.) | Evolutionary/computational | Supports removal | -EKL as targeting vs. catalytic | 94% of insect ACAT1 orthologs share -EKL; none has canonical PTS1 | Insects, >350 MY divergence | High: deep conservation as enzymatic motif |
| QuickGO IDA query | Database/direct assay | Refutes peroxisome | Whether Acat1 was confirmed | 6 proteins confirmed by IDA from PMID:22758915; Acat1 is NOT among them | QuickGO database | High: definitively closes key knowledge gap |
| Active site analysis | Structural/evolutionary | Supports thiolase II | Catalytic residue conservation | Acat1 and human ACAT1 share VCCTTVNK and CASICNGGGG catalytic motifs | Sequence computation | High: diagnostic for enzyme class |
| UniProt P24752 | Database record | Refutes by analogy | Human ACAT1 localization | Human ortholog annotated as mitochondrial ONLY; C-terminal -QKL | Database level | High: well-characterized ortholog |
| GO_Central (IBA) | Phylogenetic/evolutionary | Supports mitochondrial | Conservation of localization | Orthologous proteins across species are mitochondrial | Phylogenetic inference | Moderate: phylogenetic, not direct |
The peroxisome CC annotation for Acat1 should be removed. The evidence supporting this recommendation is:
The mitochondrion CC annotation should be retained. It is supported by HDA evidence from LOPIT proteomics (PMID: 19317464), IBA evidence from GO_Central, and is consistent with the functional context of thiolase II activity (ketone body catabolism, isoleucine catabolism) in the mitochondrial matrix.
A curator may also consider whether "mitochondrial matrix" (GO:0005759) would be a more specific and accurate CC term than "mitochondrion" (GO:0005739), given that thiolase II functions in the matrix. However, this would require experimental evidence specifically demonstrating matrix localization (e.g., protease protection assay, submitochondrial fractionation), which is not currently available for Drosophila Acat1.
The ISM evidence code from PMID:22758915 was applied computationally and has not been curated with experimental validation. The appropriate curation action is removal of the GO:0005777 annotation, not downgrading, since there is no experimental evidence that would support retaining it at any confidence level.
Acat1 (acetoacetyl-CoA thiolase / thiolase II) catalyzes the reversible Claisen condensation of two acetyl-CoA molecules to form acetoacetyl-CoA (EC 2.3.1.9). This reaction is central to:
All of these processes occur in the mitochondrial matrix.
Mitochondrial matrix:
2 Acetyl-CoA ←→ Acetoacetyl-CoA + CoA-SH
(Acat1 / thiolase II)
↓
HMG-CoA → Acetoacetate → β-hydroxybutyrate
(ketogenesis, if applicable)
Isoleucine → ... → 2-methylacetoacetyl-CoA → Acetyl-CoA + Propionyl-CoA
(Acat1, thiolytic cleavage)
The peroxisomal thiolase involved in fatty acid β-oxidation is a distinct enzyme type (thiolase I / 3-ketoacyl-CoA thiolase). In Drosophila, this function is performed by ScpX (Q24506), which has the canonical PTS1 signal -SKL. These are functionally and structurally distinct enzyme classes despite shared thiolase fold architecture. Active site analysis confirmed complete conservation of thiolase II diagnostic catalytic motifs (VCCTTVNK nucleophilic Cys, CASICNGGGG C-terminal catalytic Cys) between Drosophila Acat1 and human ACAT1, confirming orthology to the mitochondrial enzyme class.
The hypothesis tests a cellular component (localization) annotation, not a molecular function or biological process. The question is not whether Acat1 has thiolase activity (it does), but whether it localizes to peroxisomes. All evidence points to the mitochondrial matrix as the sole site of Acat1 activity in Drosophila, with the peroxisomal prediction arising from computational inference that was not experimentally validated.
The most significant competing evidence comes from studies in other organisms. In Dictyostelium discoideum, acetoacetyl-CoA thiolase (DdAcat) is a dual-localizing enzyme that localizes to peroxisomes, mitochondria, and the cytosol (PMID: 25911059). The abstract states: "Subcellular localization of DdAcat was investigated using a fusion protein with GFP, and it was found to be localized to peroxisomes. The findings showed that the targeting signal of DdAcat to peroxisomes is a unique nonapeptide sequence (15RMYTTAKNL23) similar to the conserved peroxisomal targeting signal-2 (PTS-2)." DdAcat uses overlapping PTS2 and MTS signals near the N-terminus, with alternative start codon usage determining the ratio of peroxisomal vs. cytosolic forms.
In mammals, AA-CoA thiolase (ACAT1) has been shown to contain both a mitochondrial targeting signal and a PTS1 at the C-terminus, with dual localization linked to cholesterol biosynthesis in peroxisomes (PMID: 11108725).
However, these precedents do not apply to Drosophila Acat1 for three critical reasons:
The Drosophila genome contains multiple thiolase-family genes:
| Gene | UniProt | Type | PTS1 | Localization (evidence) |
|---|---|---|---|---|
| Acat1 | Q9W3N9 | Thiolase II | -EKL (non-canonical) | Mitochondrion (HDA) |
| Acat2 | Q9W0H6 | Thiolase II | — | Cytoplasmic (ISS) |
| ScpX | Q24506 | Thiolase I | -SKL (canonical) | Peroxisome (ISM) |
| Mtpβ | — | Thiolase I | — | Mitochondrion (HDA) |
The ISM computational prediction may have partially conflated thiolase family members, predicting peroxisomal localization based on family membership rather than individual sequence features. ScpX, with its canonical -SKL PTS1, is the likely peroxisomal thiolase in Drosophila.
The ISM annotation from 2012 has persisted in GO databases for over a decade without experimental validation. This represents a common pattern where computational predictions become entrenched in annotation databases and are propagated through electronic annotation pipelines, even when subsequent experimental evidence contradicts them.
| Gap | What Was Checked | Why It Matters | What Would Resolve It |
|---|---|---|---|
| No direct fluorescence/immunolocalization in Drosophila | Literature search; only LOPIT proteomics available | LOPIT provides compartment-level resolution but co-purification artifacts are possible | GFP-tagged Acat1 in Drosophila S2 cells, co-stained with MitoTracker and peroxisomal markers |
| No submitochondrial localization data | UniProt, GO annotations | Thiolase II should be in the matrix; confirmation would enable more specific CC annotation | Protease protection assay on isolated Drosophila mitochondria |
| ISM prediction algorithm details unknown | PMID:22758915 abstract | Understanding why Acat1 was predicted might reveal threshold issues | Review full text and supplementary methods of Faust et al. 2012 |
| No functional complementation data | Literature search | Would confirm Acat1 cannot replace peroxisomal thiolase | Express Acat1 in ScpX-null Drosophila; test peroxisomal β-oxidation |
| Possible low-level dual localization below LOPIT detection | LOPIT is bulk proteomics | Minor dual localization (<5%) might be real but functionally insignificant | Quantitative immunoelectron microscopy; proximity labeling (BioID/APEX) in peroxisomes |
| Whether -EKL functions as PTS1 in any organism | PubMed search (no results found) | Would establish whether this variant can mediate import | Reporter assay with -EKL C-terminal peptide |
GFP-Acat1 localization in S2 cells: Express Acat1-GFP (or GFP-Acat1) in Drosophila S2 cells with simultaneous MitoTracker and peroxisomal marker (anti-Pmp70 or SKL-RFP) staining. This would definitively resolve the localization question with direct microscopic evidence.
C-terminal swap experiment: Replace Acat1's -EKL with canonical -SKL and test whether the mutant acquires peroxisomal localization. This would demonstrate whether the -EKL → -SKL substitution is sufficient to redirect targeting, confirming that -EKL is non-functional as PTS1.
Pex5p binding assay: Test whether Acat1's C-terminal peptide binds Pex5p (PTS1 receptor) in vitro. Compare with ScpX C-terminal peptide (-SKL) as positive control. This would directly test the biophysical basis of the targeting prediction.
PTS1 prediction scoring: Run Acat1 through established PTS1 prediction tools (e.g., PTS1 Predictor from Neuberger et al.) to obtain a quantitative score. Compare with ScpX and the six experimentally confirmed peroxisomal proteins from Faust et al.
Proximity labeling proteomics: Perform APEX2 or BioID labeling of Drosophila peroxisomal matrix using a PTS1-tagged proximity labeling enzyme. Check whether Acat1 peptides are detected above background.
Critical finding: Acat1 was NOT among the experimentally confirmed proteins (verified via QuickGO IDA query)
Tan et al. 2009 — Mapping organelle proteins and protein complexes in Drosophila melanogaster (PMID: 19317464)
Establishes Drosophila as cholesterol auxotroph, eliminating the metabolic rationale for peroxisomal ACAT1
Ishibashi et al. 2015 — Dictyostelium acetoacetyl-CoA thiolase is a dual-localizing enzyme (PMID: 25911059)
Demonstrates dual localization in Dictyostelium via PTS2/MTS overlap — a mechanism unavailable to Drosophila
Olivier & Krisans 2000 — Identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes (PMID: 11108725)
No direct microscopy for Drosophila Acat1: The strongest experimental evidence (LOPIT) is proteomics-based; fluorescence or immunogold EM localization would be more definitive but is not available.
AlphaFold is a prediction: The structural analysis of -EKL accessibility and N-terminal disorder is based on a computational model (AF-Q9W3N9-F1, v6), not an experimental crystal or cryo-EM structure.
Low-level dual localization cannot be excluded: It remains formally possible that a small fraction of Acat1 localizes to peroxisomes below the detection threshold of LOPIT. However, even if true, this would be functionally insignificant and would not justify a GO annotation without supporting experimental evidence.
ISM algorithm not fully characterized: Without access to the full prediction method used by Faust et al. 2012, we cannot determine exactly why Acat1 was flagged as potentially peroxisomal.
Negative evidence limitations: The absence of Acat1 from the IDA-confirmed set does not prove it is NOT peroxisomal — it proves only that Faust et al. did not experimentally confirm it. However, combined with the sequence, structural, evolutionary, and metabolic evidence, the weight of evidence strongly favors removal.